Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Urology|January 4, 2020
Determining Clinically Based Factors Associated With Reclassification in the Pre-MRI Era using a Large Prospective Active Surveillance CohortJustin R Gregg, John W Davis, Chad Reichard, et al.
European Urology|December 6, 2020
Ductal Prostate Cancers Demonstrate Poor Outcomes with Conventional TherapiesWeranja Ranasinghe, Daniel D Shapiro, Hyunsoo Hwang, et al.
Urologic Oncology|January 23, 2024
The association of body mass index with tumor aggression among men undergoing radical prostatectomyJustin R Gregg, Resa Magill, Andrew M Fang, et al.
Biomarker Research|November 10, 2024
Validation of a prognostic blood-based sphingolipid panel for men with localized prostate cancer followed on active surveillanceJustin R Gregg, Lisa Newcomb, Ranran Wu, et al.
Cancer|November 20, 2019
Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trendsChad Tang, Karen E Hoffman, Pamela K Allen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2025
HIGH-DOSE CHEMOTHERAPY FOR MULTIPLY OR POOR-RISK RELAPSED GERM-CELL TUMORSYago Nieto, John F Ward, Wayne Hofstetter, et al.
JAMA Network Open|October 24, 2024
Postprostatectomy Radiotherapy Timing and Long-Term Health-Related Quality of LifeSagar A Patel, Dattatraya Patil, Joseph Smith, et al.
European Urology|March 15, 2026
A Phase 2, Randomized, Controlled Trial of Best Systemic Therapy Versus Best Systemic Therapy with Definitive Treatment of the Primary Tumor in Metastatic Prostate CancerBrian F Chapin, Marc Smaldone, Amado J Zurita, et al.
Cancer Discovery|May 13, 2026
A Spatial Atlas of Muscle-Invasive Bladder Cancer Reveals Lineage-Specific Vulnerabilities and Immune ArchitectureKai Yu, Jianfeng Chen, Yu-Yi Chu, et al.
Pageof 4